NHL mAb
/ LifeArc
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
September 03, 2015
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
(clinicaltrials.gov)
- P2; N=20; Recruiting; Sponsor: Fred Hutchinson Cancer Research Center; Trial primary completion date: Oct 2015 ➔ Apr 2016
Trial primary completion date • Biosimilar
September 03, 2015
Motor Cortex Stimulation for Parkinson's Disease
(clinicaltrials.gov)
- P=N/A; N=13; Completed; Sponsor: Catholic University, Italy; Recruiting ➔ Completed; N=20 ➔ 13; Trial primary completion date: Jun 2010 ➔ Jun 2013
Enrollment change • Trial completion • Trial primary completion date • Biosimilar • Parkinson's Disease
September 03, 2015
A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis
(clinicaltrials.gov)
- P4; N=0; Withdrawn; Sponsor: Astellas Pharma Inc; N=350 ➔ 0
Enrollment change • Biosimilar
September 03, 2015
asn01-Dietary Intervention of Stress-Induced Neurovegetative Disorders With a Specific Amino Acid Composition (asn01)
(clinicaltrials.gov)
- P3; N=80; Completed; Sponsor: Kyberg Vital GmbH; Recruiting ➔ Completed; N=60 ➔ 80
Enrollment change • Trial completion • Biosimilar
September 03, 2015
Safety Study of Rituximab (Rituxan®) in Chronic Urticaria
(clinicaltrials.gov)
- P1/2; N=15; Terminated; Sponsor: Johns Hopkins University; Suspended ➔ Terminated; Trial primary completion date: Dec 2008 ➔ May 2007
Trial primary completion date • Trial termination • Biosimilar • Immunology • Inflammation
1 to 5
Of
5
Go to page
1